Mostrar el registro sencillo del ítem

Metformin may reduce Alzheimer's disease risk by increasing soluble amyloid-beta42 levels

dc.rights.licenseopenen_US
hal.structure.identifierImmunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorDALY, Timothy
dc.contributor.authorIMBIMBO, Bruno P
dc.date.accessioned2024-12-13T09:21:52Z
dc.date.available2024-12-13T09:21:52Z
dc.date.issued2024-11-08
dc.identifier.issn1460-2156en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/203915
dc.language.isoENen_US
dc.title.enMetformin may reduce Alzheimer's disease risk by increasing soluble amyloid-beta42 levels
dc.title.alternativeBrainen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1093/brain/awae367en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed39512195en_US
bordeaux.journalBrain - A Journal of Neurologyen_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.institutionCNRS
bordeaux.teamACTIVE_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-04835515
hal.version1
hal.date.transferred2024-12-13T09:21:54Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Brain%20-%20A%20Journal%20of%20Neurology&rft.date=2024-11-08&rft.eissn=1460-2156&rft.issn=1460-2156&rft.au=DALY,%20Timothy&IMBIMBO,%20Bruno%20P&rft.genre=article


Archivos en el ítem

ArchivosTamañoFormatoVer

No hay archivos asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem